| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Arcellx, Inc. | 10%+ Owner | Common Stock | 6.72M | $371M | $55.27 | 28 Dec 2023 | Direct |
| Arcus Biosciences, Inc. | 10%+ Owner | Common Stock | 31.4M | $346M | $11.00 | 18 Feb 2025 | Direct |
| ASSEMBLY BIOSCIENCES, INC. | 10%+ Owner | Common Stock | 4.51M | $100M | $22.26 | 08 Aug 2025 | Direct |
| Xilio Therapeutics, Inc. | 10%+ Owner | Prefunded Warrants (right to buy) | 36.6M | $27.5M | $0.75 | 26 Nov 2025 | Direct |
| LEAP THERAPEUTICS, INC. | 10%+ Owner | Common Stock | 5.32M | $15.2M | $2.85 | 10 Apr 2024 | Direct |
| HOOKIPA Pharma Inc. | 10%+ Owner | Common Stock | 18.8M | $13.6M | $0.73 | 20 Dec 2023 | Direct |
| Allovir, Inc. | 10%+ Owner | Common Stock | 16.6M | $11.2M | $0.67 | 27 Jun 2023 | Direct |
| Xilio Therapeutics, Inc. | 10%+ Owner | Common Stock | 9.11M | $9.47M | $1.04 | 18 Dec 2024 | Direct |
| Xilio Therapeutics, Inc. | 10%+ Owner | Series A Warrants (right to buy) | 13.3M | 05 Jun 2025 | Direct | ||
| Xilio Therapeutics, Inc. | 10%+ Owner | Series C Warrants (right to buy) | 13.3M | 05 Jun 2025 | Direct | ||
| Kyverna Therapeutics, Inc. | 10%+ Owner | Common Stock | 4.13M | 12 Feb 2024 | Direct | ||
| ASSEMBLY BIOSCIENCES, INC. | 10%+ Owner | Class A warrants to purchase Common Stock | 1.15M | 08 Aug 2025 | Direct | ||
| ASSEMBLY BIOSCIENCES, INC. | 10%+ Owner | Class B warrants to purchase Common Stock | 1.15M | 08 Aug 2025 | Direct | ||
| Kyverna Therapeutics, Inc. | 10%+ Owner | Series A-2 Convertible Preferred Stock | 0 | 12 Feb 2024 | Direct | ||
| Kyverna Therapeutics, Inc. | 10%+ Owner | Series B Convertible Preferred Stock | 0 | 12 Feb 2024 | Direct | ||
| Xilio Therapeutics, Inc. | 10%+ Owner | Series B Warrants (right to buy) | 0 | 26 Nov 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| XLO | Xilio Therapeutics, Inc. | 26 Nov 2025 | 2 | $10M | 4 | 10%+ Owner | 01 Dec 2025, 16:36 |
| ASMB | ASSEMBLY BIOSCIENCES, INC. | 08 Aug 2025 | 3 | $0 | 4 | 10%+ Owner | 03 Oct 2025, 16:30 |
| XLO | Xilio Therapeutics, Inc. | 05 Jun 2025 | 4 | $0 | 4 | 10%+ Owner | 06 Jun 2025, 19:31 |
| RCUS | Arcus Biosciences, Inc. | 18 Feb 2025 | 1 | $15M | 4 | 10%+ Owner | 20 Feb 2025, 19:42 |
| ASMB | ASSEMBLY BIOSCIENCES, INC. | 19 Dec 2024 | 1 | $20.1M | 4 | 10%+ Owner | 23 Dec 2024, 20:26 |
| XLO | Xilio Therapeutics, Inc. | 18 Dec 2024 | 2 | $8.17M | 4 | 10%+ Owner | 19 Dec 2024, 16:19 |
| ASMB | ASSEMBLY BIOSCIENCES, INC. | 17 Jun 2024 | 2 | $0 | 4 | 10%+ Owner | 20 Jun 2024, 20:31 |
| LPTX | LEAP THERAPEUTICS, INC. | 10 Apr 2024 | 0 | $0 | 3 | 10%+ Owner | 19 Apr 2024, 16:31 |
| XLO | Xilio Therapeutics, Inc. | 02 Apr 2024 | 2 | $3.32M | 4 | 10%+ Owner | 03 Apr 2024, 18:50 |
| XLO | Xilio Therapeutics, Inc. | 27 Mar 2024 | 0 | $0 | 3 | 10%+ Owner | 03 Apr 2024, 18:48 |
| KYTX | Kyverna Therapeutics, Inc. | 12 Feb 2024 | 4 | $20M | 4 | 10%+ Owner | 13 Feb 2024, 17:48 |
| KYTX | Kyverna Therapeutics, Inc. | 07 Feb 2024 | 0 | $0 | 3 | 10%+ Owner | 07 Feb 2024, 17:35 |
| RCUS | Arcus Biosciences, Inc. | 29 Jan 2024 | 1 | $320M | 4 | 10%+ Owner | 31 Jan 2024, 17:00 |
| ACLX | Arcellx, Inc. | 28 Dec 2023 | 0 | $0 | 3 | 10%+ Owner | 28 Dec 2023, 17:09 |
| HOOK | HOOKIPA Pharma Inc. | 20 Dec 2023 | 0 | $0 | 3 | 10%+ Owner | 22 Dec 2023, 16:07 |
| ASMB | ASSEMBLY BIOSCIENCES, INC. | 16 Oct 2023 | 0 | $0 | 3 | 10%+ Owner | 25 Oct 2023, 19:15 |
| RCUS | Arcus Biosciences, Inc. | 28 Jun 2023 | 1 | $19.5M | 4 | 10%+ Owner | 30 Jun 2023, 15:12 |
| ALVR | Allovir, Inc. | 27 Jun 2023 | 1 | $11M | 4 | 10%+ Owner | 28 Jun 2023, 17:17 |
| ALVR | Allovir, Inc. | 28 Jul 2022 | 0 | $0 | 3 | 10%+ Owner | 05 Aug 2022, 17:45 |
| HOOK | HOOKIPA Pharma Inc. | 15 Feb 2022 | 0 | $0 | 3 | 10%+ Owner | 17 Feb 2022, 13:45 |